Cell and Tissue Engineering Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Ortopedico Galeazzi; PhD School in Life Sciences, Department of Biotechnology and Biosciences, University of Milano-Bicocca; Milan, Italy.
Cell and Tissue Engineering Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Ortopedico Galeazzi.
Thromb Res. 2016 Apr;140 Suppl 1:S180-1. doi: 10.1016/S0049-3848(16)30145-1. Epub 2016 Apr 8.
Metastases are responsible for more than 90% of cancer related mortality. The hematogenous metastatic invasion is a complex process in which the endothelium plays a key role. Extravasation is a dynamic process involving remodeling and change in cell shape and in cytoskeleton whereby a series of strongly dependent interactions between CTCs and endothelium occurs [1]. Talins are proteins regulating focal adhesions and cytoskeleton remodeling. Talin-1 seems to be involved in the aggressiveness, motility, survival and invadopodia formation of cancer cells throughout the entire metastatic cascade [2], being up-regulated in breast cancer cells and mutated in sarcomas. Understand the implication of talin-1 in extravasation could facilitate the design of new therapies and finally fight cancer.
We hypothesized that Talin-1 could be specifically involved in extravasation driving each of its steps.
We developed a human 3D microfluidic model that enables the study of human cancer cell extravasation within a perfusable human microvascularized organ specific environment[3]. For the study of extravasation we applied microfluidic approach through the development of a microfluidic device in which endothelial cells and fibroblasts generated a 3D human functional vascular networks. Microvessel characterization was performed with immunofluorescence and permeability assays. We knocked-down talin-1 in triple negative breast cancer cell line MDA-MB231 and metastatic fibro-sarcoma cell line HT1080 with SiRNA and verified by Western-blot. Cancer cells were then perfused in the vessels and extravasation monitored through confocal imaging.
We developed a human vascularized 3D microfluidic device with human perfusable capillary-like structures embedded in fibrin matrix, characterized by mature endothelium markers and physiological permeability (1.5±0.76)×10(-6) cm/s. We focused on the role of Talin-1 in adhesion to endothelium, trans-endothelial migration (TEM) and early invasion. Adhesion to the endothelium, TEM and migration within the ECM were monitored through confocal analyses. We demonstrated that Talin-1 KD significantly reduced the adhesion efficiency and TEM in both cell lines. Early invasion was also strongly and statistically reduced by the SiRNA treatment in both cell lines.
We proved Talin-1 function in driving the extravasation mechanism in a human 3D vascularized environment. We demonstrated that Talin-1 is involved in each part of extravasation significantly affecting adhesion, TEM and the invasion stages. Targeting this protein could thus be an effective strategy to block metastasis.
转移是导致 90%以上癌症相关死亡的原因。血源性转移侵袭是一个复杂的过程,其中内皮细胞起着关键作用。渗出是一个动态过程,涉及细胞形状和细胞骨架的重塑和改变,其中循环肿瘤细胞(CTC)和内皮细胞之间发生一系列强烈依赖的相互作用[1]。塔林是调节粘着斑和细胞骨架重塑的蛋白质。Talin-1 似乎参与了整个转移级联中癌细胞的侵袭性、迁移性、存活和侵袭伪足的形成[2],在乳腺癌细胞中上调,并在肉瘤中发生突变。了解塔林-1 在渗出中的作用可能有助于设计新的治疗方法,最终对抗癌症。
我们假设 Talin-1 可能专门参与驱动渗出的每一个步骤。
我们开发了一种人类 3D 微流控模型,使我们能够在可灌注的人类微血管化器官特异性环境中研究人类癌细胞的渗出[3]。为了研究渗出,我们通过开发一种微流控装置应用微流控方法,其中内皮细胞和成纤维细胞生成 3D 人类功能性血管网络。通过免疫荧光和通透性测定对微血管进行了特征描述。我们用 siRNA 敲低三阴性乳腺癌细胞系 MDA-MB231 和转移性纤维肉瘤细胞系 HT1080 中的塔林-1,并通过 Western blot 进行验证。然后将癌细胞灌注到血管中,并通过共聚焦成像监测渗出。
我们开发了一种带有可灌注毛细血管样结构的人血管化 3D 微流控装置,该结构嵌入纤维蛋白基质中,具有成熟的内皮细胞标志物和生理通透性(1.5±0.76)×10(-6)cm/s。我们专注于 Talin-1 在与内皮细胞粘附、跨内皮迁移(TEM)和早期侵袭中的作用。通过共聚焦分析监测与内皮细胞的粘附、TEM 和细胞外基质内的迁移。我们证明 Talin-1 KD 显著降低了两种细胞系的粘附效率和 TEM。siRNA 处理也强烈且统计学上降低了两种细胞系的早期侵袭。
我们证明了 Talin-1 在人 3D 血管化环境中驱动渗出机制的功能。我们证明 Talin-1 参与渗出的各个部分,显著影响粘附、TEM 和侵袭阶段。靶向这种蛋白质可能是阻止转移的有效策略。